MYP_089601
Basic Information
Brentuximab vedotin
Anticancer
Antiviral
Standard
38 amino acids
C193H299N47O57S
Standard
Sequence
QIQLQQSGPEVVKPGASVKISCKASGYTFTDYYITWVK
Physicochemical Analysis
4221.78 Da
8.94
1.75
1.52
0.0460
-0.21
0.53
0.09
35.21
76.84
0.1316
9970.00
9970.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1691.57
-16.14
59.0
60.0
136.0
298.0
8.0
41.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0165129 VERIFIED: NO
Provenance & Taxonomy
Homo sapiens [Animal]; Mus musculus [Animal]
Monoclonal antibody
9606;10090
Structure & Mods
cyclic peptide scaffold [Cyclic]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Anticancer
Terminal half-life is 4-6 days